With the advent of erythropoietin replacement therapy, ferritin was shown to remain a reliable indicator of iron status, allowing patients at risk of true iron deficiency to be treated prophylactically, mainly (as advocated at that time) with oral iron supplements when the serum ferritin was less than 50 μg/L [29, 30]. This evidence concerns the gene EPO and nutritional disorder.